CSIMarket



Davita Inc   (DVA)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

DVA's Revenue Growth by Quarter and Year

Davita Inc 's Revenue results by quarter and year




DVA Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 2,943.97 2,905.32 2,898.58
III Quarter September - 2,938.32 2,924.07 2,904.08
II Quarter June - 2,916.51 2,879.98 2,842.71
I Quarter March 2,817.56 2,820.00 2,841.24 2,743.11
FY   2,817.56 11,618.80 11,550.61 11,388.48



DVA Revenue first quarter 2022 Y/Y Growth Comment
Davita Inc reported decrease in Revenue in the first quarter 2022 by -0.09% to $ 2,817.56 millions, from the same quarter in 2021.
The decrease in the first quarter 2022 Davita Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 3.27%.

Looking into first quarter 2022 results within Healthcare Facilities industry 30 other companies have achieved higher Revenue growth. While Davita Inc ' s Revenue decline of -0.09% ranks overall at the positon no. 1549 in the first quarter 2022.




DVA Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 1.33 % 0.23 % 2.75 %
III Quarter September - 0.49 % 0.69 % 1.99 %
II Quarter June - 1.27 % 1.31 % -1.53 %
I Quarter March -0.09 % -0.75 % 3.58 % -49.82 %
FY   - 0.59 % 1.42 % -18.78 %

Financial Statements
Davita Inc 's first quarter 2022 Revenue $ 2,817.56 millions DVA's Income Statement
Davita Inc 's first quarter 2021 Revenue $ 2,820.00 millions Quarterly DVA's Income Statement
New: More DVA's historic Revenue Growth >>


DVA Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 0.19 % -0.64 % -0.19 %
III Quarter September - 0.75 % 1.53 % 2.16 %
II Quarter June - 3.42 % 1.36 % 3.63 %
I Quarter March -4.29 % -2.94 % -1.98 % -2.77 %
FY (Year on Year)   - 0.59 % 1.42 % -18.78 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #31
Healthcare Sector #188
Overall #1549

Revenue Y/Y Growth Statistics
High Average Low
152.13 % 3.27 % -22.82 %
(Dec 31 2013)   (Sep 30 2018)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #31
Healthcare Sector #188
Overall #1549
Revenue Y/Y Growth Statistics
High Average Low
152.13 % 3.27 % -22.82 %
(Dec 31 2013)   (Sep 30 2018)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Davita Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
317.43 % 8.87 % -79.99 %
(Mar 31 2018)  


DVA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Davita Inc reported fall in Revenue from the previous quarter by -4.29% to $ 2,817.56 millions, from $ 2,943.97 millions released in the previous quarter.

If you look into recent slump in the I. Quarter 2022, you suppose to assume, that frequently I. Quarter Revenue appear to be weaker relative to the forth quarter

Within Healthcare Facilities industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Davita Inc 's Revenue growth quarter on quarter, overall rank is 1265.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #31
Healthcare Sector #146
Overall #1265
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #31
Healthcare Sector #146
Overall #1265
Revenue Q/Q Growth Statistics
High Average Low
317.43 % 8.87 % -79.99 %
(Mar 31 2018)  


DVA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Davita Inc reported fall in Revenue from the forth quarter by -4.29% to $ 2,817.56 millions, from $ 2,943.97 millions declared a quarter before.

It's not huge issue, as Davita Inc 's Revenue generally gravitate to dip in the I. Quarter.

Within Healthcare Facilities industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Davita Inc 's Revenue growth quarter on quarter, overall rank is 1265.


Davita Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 11,616.35 $ 11,618.80 $ 11,580.15 $ 11,565.90 $ 11,529.37
Y / Y Revenue Growth (TTM) 0.75 % 0.59 % 0.31 % 0.36 % 0.37 %
Year on Year Revenue Growth Overall Ranking # 1612 # 501 # 2645 # 2244 # 1728
Seqeuential Revenue Change (TTM) -0.02 % 0.33 % 0.12 % 0.32 % -0.18 %
Seq. Revenue Growth (TTM) Overall Ranking # 1549 # 2350 # 2852 # 2788 # 1672




Cumulative Revenue growth Comment
Although Davita Inc 's Annual Revenue growth year on year were below company's average 17.98% , Revenue announced in the Mar 31 2022 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.75% year on year, from 0.59% in Dec 31 2021.

In the Healthcare sector 182 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 501 to 1612.

Revenue TTM Q/Q Growth Statistics
High Average Low
152.13 %
3.27 %
-22.82 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 31
Healthcare Sector # 183
Overall # 1612

Revenue TTM Y/Y Growth Statistics
High Average Low
329.48 %
17.98 %
-50.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 31
Sector # 188
S&P 500 # 1549
Cumulative Revenue growth Comment
Although Davita Inc 's Annual Revenue growth year on year were below company's average 17.98% , Revenue announced in the Mar 31 2022 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.75% year on year, from 0.59% in Dec 31 2021.

In the Healthcare sector 182 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 501 to 1612.

Revenue TTM Q/Q Growth Statistics
High Average Low
152.13 %
3.27 %
-22.82 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 31
Healthcare Sector # 183
Overall # 1612

Revenue TTM Y/Y Growth Statistics
High Average Low
329.48 %
17.98 %
-50.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 31
Sector # 188
S&P 500 # 1549




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DVA's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for DVA's Competitors
Revenue Growth for Davita Inc 's Suppliers
Revenue Growth for DVA's Customers

You may also want to know
DVA's Annual Growth Rates DVA's Profitability Ratios DVA's Asset Turnover Ratio DVA's Dividend Growth
DVA's Roe DVA's Valuation Ratios DVA's Financial Strength Ratios DVA's Dividend Payout Ratio
DVA's Roa DVA's Inventory Turnover Ratio DVA's Growth Rates DVA's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Hydrofarm Holdings Group Inc -0.01%$ -0.011 millions
Sage Therapeutics Inc -0.06%$ -0.063 millions
Davita Inc -0.09%$ -0.087 millions
Axogen inc -0.10%$ -0.097 millions
Oncternal Therapeutics Inc -0.27%$ -0.267 millions
Glaukos Corp-0.42%$ -0.422 millions
Collegium Pharmaceutical inc -0.70%$ -0.699 millions
Tenet Healthcare Corp-0.75%$ -0.753 millions
Nevro Corp -0.87%$ -0.867 millions
Antares Pharma Inc -1.25%$ -1.250 millions
Elanco Animal Health Inc-1.37%$ -1.369 millions
Nanostring Technologies Inc -1.70%$ -1.698 millions
Mimedx Group Inc -1.79%$ -1.789 millions
Exagen Inc -1.82%$ -1.823 millions
Royalty Pharma Plc-1.92%$ -1.916 millions
Veru Inc -2.34%$ -2.339 millions
Delcath Systems Inc -2.58%$ -2.577 millions
Ikena Oncology Inc -2.59%$ -2.591 millions
Ngm Biopharmaceuticals Inc -2.91%$ -2.906 millions
Livanova Plc-3.00%$ -3.000 millions
Lifevantage Corp-3.04%$ -3.037 millions
Reata Pharmaceuticals Inc -3.18%$ -3.178 millions
Bio rad Laboratories Inc -3.68%$ -3.678 millions
Codiak Biosciences Inc -3.69%$ -3.692 millions
Vanda Pharmaceuticals Inc -3.95%$ -3.953 millions
Quest Diagnostics Inc-4.01%$ -4.007 millions
Organogenesis Holdings Inc -4.32%$ -4.325 millions
Myriad Genetics Inc -4.74%$ -4.737 millions
Bausch Health Companies Inc -5.38%$ -5.377 millions
Viatris Inc -5.39%$ -5.386 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BEAG's Profile

Stock Price

BEAG's Financials

Business Description

Fundamentals

Charts & Quotes

BEAG's News

Suppliers

BEAG's Competitors

Customers & Markets

Economic Indicators

BEAG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071